Characteristics of Cardiac Tumor and the Risk Stratification of Subsequent Adverse Events (UNIQUE) — UNIQUE  

Cardiac Tumor Clinical Trial

Official title: Characteristics of Cardiac Tumor and the Risk Stratification of Subsequent Adverse Events (UNIQUE): an Investigator-initiated, National, Multicenter, Retrospective-prospective, Cohort Study

Status Not yet recruiting

Clinical Trial Summary

This study aims to retrospectively and prospectively collect clinical and biological specimen data from patients with cardiac tumors who meet the inclusion and exclusion criteria. Various techniques, including general molecular biology analysis and multi-omics analysis, will be used to construct a prognostic model for cardiac tumors.

Clinical Trial Description

This study aims to construct a retrospective-prospective long-term follow-up cohort and management system for cardiac tumors through a multi-centre collaborative network. The duration of the study will be divided into retrospective and prospective components. The retrospective study will collect cases of cardiac tumors from 2003-2022; the prospective study is expected to collect cases of cardiac tumors from 2022-2030. The study is expected to assess the disease characteristics, progression patterns, clinical features, natural course and long-term prognosis of cardiac tumors. ;

Related Conditions & MeSH terms

• Cardiac Tumor

• NCT number: NCT06100328
• Study type: Observational
• Source: First Affiliated Hospital Xi'an Jiaotong University
• Contact: Guoliang Li
• Phone: +8613759982523
• Email: liguoliang_med@163.com
• Status: Not yet recruiting
• Start date: September 1, 2024
• Completion date: July 31, 2030